Related Articles
Distinct expression of Survivin splice variants in breast carcinomas
Survivin DEx3 as a biomarker of thyroid cancers: A study at the mRNA and protein level
Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy
Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
Expression of flTF and asTF splice variants in various cell strains and tissues